Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
N Engl J Med
; 388(9): 813-823, 2023 Mar 02.
Article
in En
| MEDLINE
| ID: mdl-36856617
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Neoadjuvant Therapy
/
Antineoplastic Agents, Immunological
/
Melanoma
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
N Engl J Med
Year:
2023
Document type:
Article
Country of publication: